|
Market Closed -
London S.E.
09:05:05 21/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 87.50 GBX | +1.74% |
|
+8.02% | +8.70% |
| 14/08 | EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows | AN |
| 13/08 | Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal | CI |
| Market Cap | 3.3Cr 4.42Cr 3.85Cr 3.63Cr 6.19Cr 423.03Cr 6.2Cr 43Cr 17Cr 215.51Cr 17Cr 16Cr 694.65Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 3.17Cr 4.24Cr 3.7Cr 3.48Cr 5.95Cr 406.13Cr 5.95Cr 42Cr 16Cr 206.9Cr 16Cr 16Cr 666.9Cr | EV / Sales 2026 * |
36.1x | EV / Sales 2027 * | 34.5x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AREC | Delayed | |
Deutsche Boerse AG
| 6UI | Delayed | |
|
Börse Stuttgart
| 6UI | Delayed |
Last Transcript: Arecor Therapeutics plc
| 1 day | +1.74% | ||
| 1 week | +8.02% | ||
| Current month | +18.24% | ||
| 1 month | +37.80% | ||
| 3 months | +40.00% | ||
| 6 months | +29.63% | ||
| Current year | +8.70% |
| 1 week | 77 |  | 90 |
| 1 month | 65 | | 90 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 100 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 472 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 13/04/2021 |
David J. Ellam
DFI | Director of Finance/CFO | - | 18/11/2024 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Sarah Howell
BRD | Director/Board Member | 51 | 13/04/2021 |
Mohammad Fazeli
BRD | Director/Board Member | 61 | 01/09/2017 |
Andrew Richards
CHM | Chairman | 66 | 13/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/05/26 | Free | Chief Executive Officer | 1,60,000 | 0.4238% | ||
| 20/05/26 | Free | Executive/Senior Manager | 95,000 | 0.2516% | ||
| 20/05/26 | Free | Chief Financial Officer | 1,05,000 | 0.2781% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.74% | +8.02% | +20.69% | -54.55% | 4.34Cr | |
| +0.59% | +3.31% | +1.03% | +24.53% | 4.63TCr | |
| +1.30% | +3.10% | +44.15% | +31.38% | 4.39TCr | |
| +0.95% | -5.40% | +342.72% | +548.37% | 4.09TCr | |
| +4.23% | +5.53% | +9.35% | +89.62% | 3.99TCr | |
| +1.11% | +1.80% | +11.52% | +43.15% | 2.95TCr | |
| +1.94% | +6.24% | +25.19% | +145.07% | 1.71TCr | |
| +0.37% | -9.84% | - | - | 1.55TCr | |
| +2.12% | +10.41% | +24.78% | +39.05% | 1.52TCr | |
| +0.24% | +32.23% | -11.57% | - | 1.4TCr | |
| Average | +1.41% | +4.19% | +51.98% | +108.33% | 2.62TCr | |
| Weighted average by Cap. | +1.49% | +2.08% | +70.36% | +141.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9L 11.75L 10.24L 10L 16.47L 11Cr 16.49L 1.16Cr 44.5L 5.73Cr 44.07L 43.14L 18Cr | 10.5L 14.04L 12.24L 11.53L 19.69L 13Cr 19.71L 1.38Cr 53.19L 6.85Cr 52.67L 51.56L 22Cr |
| Net income | - | - |
| Net Debt | -13.2L -17.65L -15.39L -14.49L -24.75L -17Cr -24.77L -1.74Cr -66.86L -8.61Cr -66.21L -64.81L -28Cr | 32.03L 42.82L 37.34L 35.16L 60.05L 41Cr 60.12L 4.21Cr 1.62Cr 21Cr 1.61Cr 1.57Cr 67Cr |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | GBX 87.50 | +1.74% | 11,751 |
| 18/26/18 | GBX 86.00 | 0.00% | 6,979 |
| 17/26/17 | GBX 86.00 | +0.58% | 1,182 |
| 16/26/16 | GBX 85.50 | +5.56% | 23,736 |
| 15/26/15 | GBX 81.00 | 0.00% | 79,713 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8750GBP
Average target price
2.755GBP
Spread / Average Target
+214.86%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
